U.S. market Closed. Opens in 52 minutes

CLB | Core Laboratories N.V. Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for CLB we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is very poor, Growth is desperately bad and Health is very strong.

Valuation (50%)

Company Industry
P/E Ratio (TTM) 30.42 16.13
PEG Ratio (TTM) 3.65 2.12
P/S Ratio (TTM) 1.74 1.48
P/B Ratio (TTM) 3.61 2.42
P/FCF Ratio (TTM) 17.39 12.84
Price to 5YR AVG Earnings Ratio 55.49 0.15
Price to 5YR AVG FCF Ratio 27.58 39.73

Profitability (35%)

Company Industry
ROA (TTM) 5.07% 8.50%
ROE (TTM) 12.78% 19.63%
Net Profit Margin (TTM) 5.83% 11.12%
ROIC 5YR AVG 9.11% 6.50%

Growth (27%)

4QTR AVG 3YR AVG 5YR AVG
EPS 31.80% -32.52% -39.51%
Revenue 1.76% -8.81% -25.29%
Net Income 32.54% -25.42% -35.25%
Cash Flow 2,283.75% -30.70% -24.91%

Health (74%)

Company Industry
Current Ratio (TTM) 2.48 1.89
Quick Ratio (TTM) 1.79 1.35
D/E Ratio (TTM) 0.76 0.70
Interest Coverage (TTM) 4.38 14.06
Piotroski F-Score 6 7
Altman Z-Score 3.39 2.99
LTL to 5YR AVG FCF 4.94 8.58
Shares Outstanding Growth 5YR AVG 1.04% 7.97%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙